Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Heska Corporation (HSKA) stocks in Canada

Learn how to easily invest in Heska Corporation stocks.

Heska Corporation is a medical devices business based in the US. Heska Corporation stocks (HSKA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $230.72 – a decrease of 11.52% over the previous week. Heska Corporation employs 602 staff and has a trailing 12-month revenue of around $250 million.

How to buy shares in Heska Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HSKA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Heska Corporation stock price (NASDAQ:HSKA)

Use our graph to track the performance of HSKA stocks over time.

Heska Corporation shares at a glance

Information last updated 2022-01-24.
Latest market close$129.75
52-week range$138.56 - $275.94
50-day moving average $166.50
200-day moving average $213.47
Wall St. target price$238.60
PE ratio 776.6666
Dividend yield N/A (0%)
Earnings per share (TTM) $0.19

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Heska Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Heska Corporation price performance over time

Historical closes compared with the close of $129.75 from 2022-01-27

1 week (2022-01-21) -11.52%
1 month (2021-12-28) -26.59%
3 months (2021-10-28) -42.76%
6 months (2021-07-28) -48.04%
1 year (2021-01-28) -25.38%
2 years (2020-01-28) 25.28%
3 years (2019-01-28) 35.16%
5 years (2017-01-27) 62.29%

Is Heska Corporation under- or over-valued?

Valuing Heska Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Heska Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Heska Corporation's P/E ratio

Heska Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 777x. In other words, Heska Corporation shares trade at around 777x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Heska Corporation's PEG ratio

Heska Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Heska Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Heska Corporation's EBITDA

Heska Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19.1 million.

The EBITDA is a measure of a Heska Corporation's overall financial performance and is widely used to measure a its profitability.

Heska Corporation financials

Revenue TTM $250 million
Operating margin TTM 2.93%
Gross profit TTM $81.3 million
Return on assets TTM 0.93%
Return on equity TTM 0.53%
Profit margin 0.75%
Book value $40.64
Market capitalisation $1.6 billion

TTM: trailing 12 months

Heska Corporation share dividends

We're not expecting Heska Corporation to pay a dividend over the next 12 months.

Have Heska Corporation's shares ever split?

Heska Corporation's shares were split on a 1:10 basis on 29 December 2010. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heska Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Heska Corporation shares which in turn could have impacted Heska Corporation's share price.

Heska Corporation share price volatility

Over the last 12 months, Heska Corporation's shares have ranged in value from as little as $138.56 up to $275.94. A popular way to gauge a stock's volatility is its "beta".

HSKA.US volatility(beta: 1.56)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Heska Corporation's is 1.556. This would suggest that Heska Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Heska Corporation overview

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Additionally, the company provides a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. It sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site